We are live on ! Find out more
FCMV

Foresite Capital Management V Portfolio holdings

AUM $271M
1-Year Est. Return 309.87%
This Fund
S&P 500
This Quarter Est. Return
-22.04%
1 Year Est. Return
+309.87%
3 Year Est. Return
+356.88%
5 Year Est. Return
+250.56%
10 Year Est. Return
–
AUM
$143M
AUM Growth
-$102M
Cap. Flow
-$21.5M
Cap. Flow %
-15.01%
Top 10 Hldgs %
95.87%
Holding
17
New
–
Increased
2
Reduced
2
Closed
3

Top Buys

Rank Stock Value
1
HIMS icon
Hims & Hers Health
HIMS
+$2.61M
2
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
+$1.01M

Top Sells

Rank Stock Value
1
CGEM icon
Cullinan Oncology
CGEM
+$10.4M
2
QSI icon
Quantum-Si Incorporated
QSI
+$5.43M
3
RACB
Research Alliance Corp. II Class A Common Stock
RACB
+$4.88M
4
HLTH
Cue Health Inc. Common Stock
HLTH
+$3.16M
5
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$1.25M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRDS
1
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$28.9M 20.16%
9,400,515
– –
THRX
2
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$18.4M 12.89%
3,335,346
+122,614
+4% +$1.01M
ACRS icon
3
Aclaris Therapeutics
ACRS
$743M
$17.6M 12.27%
1,258,243
– –
SLGC
4
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$15.9M 11.1%
3,516,472
-210,000
-6% -$1.25M
HIMS icon
5
Hims & Hers Health
HIMS
$6.26B
$15M 10.51%
3,319,786
+612,864
+23% +$2.61M
CMPX icon
6
Compass Therapeutics
CMPX
$349M
$11.7M 8.15%
4,400,000
– –
KNTE
7
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$11M 7.71%
875,001
– –
ACET icon
8
Adicet Bio
ACET
$84.7M
$9.93M 6.94%
42,500
– –
IVVD icon
9
Invivyd
IVVD
$171M
$4.7M 3.28%
1,431,826
– –
IRON icon
10
Disc Medicine
IRON
$3.03B
$4.12M 2.87%
81,171
– –
QSI icon
11
Quantum-Si Incorporated
QSI
$157M
$2.15M 1.5%
924,379
-1,417,682
-61% -$5.43M
ENTA icon
12
Enanta Pharmaceuticals
ENTA
$378M
$2M 1.4%
42,250
– –
ME
13
DELISTED
23andMe Holding Co
ME
$1.01M 0.7%
20,346
– –
PHVS icon
14
Pharvaris
PHVS
$2.37B
$755K 0.53%
34,142
– –
CGEM icon
15
Cullinan Oncology
CGEM
$1.08B
– –
-992,507
Closed -$10.4M
HLTH
16
DELISTED
Cue Health Inc. Common Stock
HLTH
– –
-490,546
Closed -$3.16M
RACB
17
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
– –
-500,000
Closed -$4.88M

Similar funds

MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
RP
Ravenswood Partners Mclean, Virginia $271M AUM
PCM
Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return
VW
Veridan Wealth West Linn, Oregon $270M AUM
TP
TritonPoint Partners Chevy Chase, Maryland $272M AUM

Foresite Capital Management V's Q2 2022 Portfolio in Review

As of Q2 2022, Foresite Capital Management V held 17 positions worth $143M, down 42% from $245M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Foresite Capital Management V withdrew a net $21.5M in Q2 2022, closing 3 positions and reducing 2 holdings. Its most notable exit was Cullinan Oncology, an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 98% a quarter earlier, followed by Financials.

Against the trend, Foresite Capital Management V added an estimated $2.61M to Hims & Hers Health.

  • Foresite Capital Management V added most to Hims & Hers Health in Q2 2022, an estimated $2.61M increase.
  • Foresite Capital Management V's biggest Q2 2022 reduction was Quantum-Si Incorporated, cutting an estimated $5.43M.
  • Foresite Capital Management V fully exited Cullinan Oncology in Q2 2022, selling an estimated $10.4M.
  • Foresite Capital Management V's ten largest holdings make up 96% of its $143M portfolio in Q2 2022.
  • Foresite Capital Management V opened 0 new positions and closed 3 in Q2 2022.
  • Foresite Capital Management V's portfolio value fell 42% quarter-over-quarter to $143M.

Based on Foresite Capital Management V's 13F filing for Q2 2022, filed 12 Aug 2022.